Jefferies Group LLC Biogen Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$194.69 - $268.46 $5.78 Million - $7.97 Million	-29,700 Reduced 14.72%	172,100 $46 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $5.78 Million - $7.97 Million	-29,700 Reduced 14.72%	172,100 $46 Million
Q2 2022 Sep 21, 2023	BUY	$187.54 - $223.02 $20.8 Million - $24.7 Million	110,700 Added 121.51%	201,800 $41.2 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $20.8 Million - $24.7 Million	110,700 Added 121.51%	201,800 $41.2 Million
Q1 2022 Sep 21, 2023	SELL	$193.77 - $244.14 $12.1 Million - $15.3 Million	-62,700 Reduced 40.77%	91,100 $19.2 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $12.1 Million - $15.3 Million	-62,700 Reduced 40.77%	91,100 $19.2 Million
Q4 2021 Sep 21, 2023	BUY	$223.92 - $287.77 $9.2 Million - $11.8 Million	41,100 Added 36.47%	153,800 $36.9 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $9.2 Million - $11.8 Million	41,100 Added 36.47%	153,800 $36.9 Million
Q3 2021 Sep 21, 2023	BUY	$282.99 - $369.05 $17 Million - $22.1 Million	60,000 Added 113.85%	112,700 $31.9 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $17 Million - $22.1 Million	60,000 Added 113.85%	112,700 $31.9 Million
Q2 2021 Sep 21, 2023	SELL	$259.0 - $414.71 $41.9 Million - $67.1 Million	-161,900 Reduced 75.44%	52,700 $18.2 Million
Q2 2021 Aug 20, 2021	SELL	$259.0 - $414.71 $1.35 Billion - $2.16 Billion	-5,217,300 Reduced 99.0%	52,700 $18.2 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $1.31 Billion - $2.1 Billion	5,055,400 Added 2355.73%	5,270,000 $18.2 Million
Q1 2021 Sep 21, 2023	BUY	$242.95 - $284.63 $48 Million - $56.2 Million	197,600 Added 1162.35%	214,600 $60 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $48 Million - $56.2 Million	197,600 Added 1162.35%	214,600 $60 Million
Q4 2020 Sep 21, 2023	SELL	$236.26 - $355.63 $36.6 Million - $55.2 Million	-155,100 Reduced 90.12%	17,000 $4.16 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.12 Million - $4.69 Million	13,200 Added 347.37%	17,000 $4.16 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $17.1 Million - $22.7 Million	-66,200 Reduced 94.57%	3,800 $1.02 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $2.53 Million - $3.21 Million	-9,400 Reduced 11.84%	70,000 $22.1 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $3.32 Million - $4.59 Million	15,100 Added 23.48%	79,400 $23.6 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $1.96 Million - $2.19 Million	9,000 Added 16.27%	64,300 $15 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $12 Million - $13.2 Million	54,700 Added 9116.67%	55,300 $12.9 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $238,381 - $372,856	-1,100 Reduced 64.71%	600 $142,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $20 Million - $25.4 Million	-71,900 Reduced 97.69%	1,700 $512,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $20.6 Million - $26.9 Million	70,100 Added 2002.86%	73,600 $26 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $7.34 Million - $8.75 Million	-28,500 Reduced 89.06%	3,500 $1.02 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $6.56 Million - $9.27 Million	25,200 Added 370.59%	32,000 $8.76 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $1.94 Million - $2.17 Million	-6,300 Reduced 48.09%	6,800 $2.17 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $3.68 Million - $4.32 Million	13,100	13,100 $4.1 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.51 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.46 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.19 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.11 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$773 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account